Sign in

CIK 0001484612

  • Accelerated filer
  • Smaller reporting company

Outset Medical, Inc.

Sign in to watch
Ticker
OM
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
200514392
Phone
+1 669-231-8200
Business address
3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
Former names
Home Dialysis Plus, Ltd.
Open-market buys, last 90 days
$870,260
in 1 filing
Open-market sales, last 90 days
$28,997
in 2 filings

Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-01 Trigg Leslie Chair and CEO Option exercise 10b5-1 +20,000 $4.11 $82K 429,489
2023-08-01 Trigg Leslie Chair and CEO Sale 10b5-1 −20,000 $20.22 $404K 409,489
2023-08-01 Trigg Leslie Chair and CEO Option exercise · Performance Options (right to buy) 10b5-1 −20,000 25,418
2023-08-01 Ahmed Nabeel Chief Financial Officer Sale 10b5-1 −990 $20.07 $20K 90,736
2023-07-24 Nash Marc VP Manufacturing Grant or award +6,000 45,195
2023-07-24 Nash Marc VP Manufacturing Grant or award +338 45,533
2023-07-19 Brottem John L. General Counsel Option exercise 10b5-1 +1,415 $9.48 $13K 60,360
2023-07-19 Brottem John L. General Counsel Sale 10b5-1 −1,415 $20.00 $28K 58,945
2023-07-19 Brottem John L. General Counsel Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −1,415 15,560
2023-07-03 Trigg Leslie Chair and CEO Option exercise 10b5-1 +20,000 $4.11 $82K 429,489
2023-07-03 Trigg Leslie Chair and CEO Sale 10b5-1 −20,000 $20.90 $418K 409,489
2023-07-03 Trigg Leslie Chair and CEO Option exercise · Performance Options (right to buy) 10b5-1 −20,000 45,418
2023-07-03 Ahmed Nabeel Chief Financial Officer Sale 10b5-1 −990 $21.70 $21K 91,726
2023-06-20 Brottem John L. General Counsel Option exercise 10b5-1 +1,414 $9.48 $13K 60,359
2023-06-20 Brottem John L. General Counsel Sale 10b5-1 −1,414 $21.97 $31K 58,945
2023-06-20 Brottem John L. General Counsel Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −1,414 16,975
2023-06-01 Trigg Leslie Chair and CEO Option exercise 10b5-1 +20,000 $4.11 $82K 429,489
2023-06-01 Trigg Leslie Chair and CEO Sale 10b5-1 −20,000 $21.10 $422K 409,489
2023-06-01 Trigg Leslie Chair and CEO Option exercise · Performance Options (right to buy) 10b5-1 −20,000 65,418
2023-06-01 Ahmed Nabeel Chief Financial Officer Sale 10b5-1 −990 $20.83 $21K 92,716

Page 11 of 18 · 343 trades